An Investigator And Subject Blinded, Sponsor Open, Randomized, Placebo Controlled, Multiple Dose Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-05089771 In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 May 2013
At a glance
- Drugs PF 5089771 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jan 2013 New trial record
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.